© 2004 by Oxford University Press
© 2004 Oxford University Press
CORRESPONDENCE |
Re: Trends in the Treatment of Ductal Carcinoma In Situ of the Breast
Affiliations of authors: Cornell University, Weill Medical College, Department of Public Health, New York, NY (HTG); Division of Health Services Research, Department of Community & Preventive Medicine, University of Rochester School of Medicine and Dentistry, Rochester, NY (AWD)
Correspondence to: Heather T. Gold, PhD, Cornell University, Weill Medical College, Department of Public Health, 411 E. 69th St., New York, NY 10021 (e-mail: heg2001@med.cornell.edu)
| The first 10% of the full text of this article appears below. |
We applaud the study of Baxter et al. (1), in which the authors examined trends in treatments for ductal carcinoma in situ (DCIS) and the association between treatment and diagnosis year, race, tumor size, comedo histology, and geographic area by use of data from the Surveillance, Epidemiology, and End